VIM and neoplasm: Considering the higher abundance of circulating tumor cells (CTCs) in portal vein blood compared to in peripheral blood, researchers have discovered that the count of mesenchymal-CTCs and vimentin+ CTCs correlates with a poorer differentiated tumor and a shorter survival [52,53].